61% Indians sceptical about Covid vax even if it came in 2021: Survey
About 61 per cent of people have claimed they are sceptical about the Covid-19 vaccine and will not rush to take it in 2021 even if it is available, a survey revealed on Friday.
 
Scientists from around the world, including India are developing several vaccines that are at different stages of clinical trials. The central government maintains it has started to gear up to take these vaccines to every citizen.
 
'LocalCircles' conducted a survey to know the tentative perception of peoples' reaction when the Government takes Covid-19 vaccine to them finally. It also sought to know peoples' current behaviour facing COVID-19 threats, and for how long will they continue to endure the suffering from the pandemic. The survey received over 25,000 responses from over 225 districts of India.
 
The complexity of the COVID-19 disease has put formidable challenges for scientists to develop a safe and effective vaccine. A host of pharmaceutical companies are heavily engaged in trials for a vaccine but when a vaccine does become available in March-April 2021, it is important that there is a certain level of trust that people have in the vaccine.
 
To the question that asked respondents, "If the COVID-19 vaccine became available in the early part of next year, would you like to get it so you can go back to your pre-COVID lifestyle?", 61 per cent of 8,312 respondents said they are sceptical about the COVID-19 vaccine and will not rush to take it in 2021 even if it is available.
 
Only 12 per cent respondents said would get vaccinated and go back to living pre-COVID lifestyle, while 25 per cent said they will get vaccinated but still will not go back to pre-COVID lifestyle, and 10 per cent said they will not take it at all in 2021.
 
In July, Indians via LocalCircles raised the issue of an urgent need to develop serial number tracking of COVID-19 vaccine to avoid any black marketing and to track the vaccine from point of manufacturing to the point of administration.
 
The key action needed here by both the pharmaceutical industry and the Government is to keep citizens updated at every step about the vaccine via various media platforms so when a safe vaccine does arrive, the Indian citizenry is ready to take it.
 
Respondents were also asked how they feel mentally after eight months into the Covid-19 pandemic. Of 8,590 respondents, 33 per cent said they feel anxious or worried, 19 per cent said calm and happy, 13 per cent said depressed, 5 per cent said enthusiastic, 20 per cent said they were feeling thankful, while 10 per cent said none of the above.
 
India is currently in the fifth phase of unlocking, which has seen most restrictions removed. The Unlock 5.0 guidelines allow states and union territories to take a call on determining the capacity of people allowed to gather, along with the call to open schools, cinemas, multiplexes, among others.
 
While the Central and State Governments are permitting various services like markets, restaurants, metros, multiplexes, markets, parks etc. to operate the general guidelines are still to minimize social interactions, maximize social distancing, always wear mask when out of home and in general avoid crowded public places.
 
These restrictions have led to change in lifestyle for majority of the people across the country. Work from Home model has been implemented by many businesses, also leading to a significant change in the lifestyles of their employees.
 
To understand if people are tired of the new pandemic induced lifestyle, LocalCircles asked people, "How long do you think you can easily sustain this post Covid way of living with restriction?"
 
Out of 8,496 citizens participated, of which 38 per cent said they are willing to live the Covid-19 way of living for as long as it takes, while 23 per cent said they are already tired of the restrictions.
 
While 14 per cent each said till December 31, 2020 and till March 31, 2021, 6 per cent said till June 30, 2021, 2 per cent said till September 30, 2021, and 3 per cent said till Dec 31, 2021.
 
If the numbers are added up, 63 per cent citizens feel they can easily sustain the post Covid way of living with restrictions till March 31, 2021.
 
Disclaimer: Information, facts or opinions expressed in this news article are presented as sourced from IANS and do not reflect views of Moneylife and hence Moneylife is not responsible or liable for the same. As a source and news provider, IANS is responsible for accuracy, completeness, suitability and validity of any information in this article.
  • Like this story? Get our top stories by email.

    User 

    COMMENTS

    saioamshyd

    1 month ago

    https://mail.google.com/mail/u/0/?tab=rm&ogbl#inbox/FMfcgxwKjBLSxZVvZMrtnGqjDcCZBchM
    1. When majority of Indians are skeptical on the delayed advent of China Virus [corona] vaccine , the indecision of GOI-AYUSH MINISTRY , headed by Dr.Harsha Vardhan shall take more lives in thousands. If an earning member dies of Corona, entire dependents' life is jeopardised.
    2. 2nd advisory on Ayurveda is issued. DRDA's research Ayurveda product is highly effective against an enlarged prostate gland. Silence on Homeo medication for prophylaxis/cure is very dangerous. Homeo deals with 3000+ formulae [earlier it had 1000+ formulae] to address any disease ailment including cancer/China virus/Dengue..
    3. May I request Dr.Harshavardhan, UHM to issue an order permitting Homeo doctors also to address China virus Prophylaxis & cure.
    4. https://lnkd.in/f6eNdcv.
    5. SATYAMAEVA JAYATHE!!!

    Maharashtra Caps Prices of N-95 Mask at Rs49 and Layered Masks at Rs4
    Paying heed to the crying need for restricting profiteering on masks, the public interest litigation (PIL) filed in the Bombay High Court and a report submitted by an expert committee, the Maharashtra government has decided to cap prices of masks used in the fight against coronavirus (COVID-19). 
     
    While the price of an N95 mask is capped at Rs49, those of the layered masks would be limited to Rs4 per piece
     
    As per the state government decision, price of NIOSH certified N95 V shape masks is capped at Rs19, which is lowest in this category. Magnum make N95 MH cup mask is priced at a maximum price of Rs49. 
     
    Doctors kit of five N95 masks plus five three-ply melt blown mask, including Venus doctors kit is priced at Rs127, as per the government order.
     
    Prices of two-ply and three-ply surgical masks are fixed at Rs3 and Rs4, respectively.
     
    Here are the capped prices of N95 and other masks…
     
  • Like this story? Get our top stories by email.

    User 

    COMMENTS

    saharaaj

    1 month ago

    In markets it is available 25 this will facilitate high profit to sellers they will quote Govt order

    Johnson & Johnson pauses Covid-19 vaccine trial
    US pharmaceutical giant Johnson & Johnson announced that it has temporarily paused its Covid-19 vaccine trial after a participant became unwell.
     
    "We have temporarily paused further dosing in all our Covid-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant," Xinhua news agency quoted the company as saying in a statement on Monday.
     
    The patient's condition was being reviewed and evaluated by the ENSEMBLE independent Data Safety Monitoring Board as well as internal clinical and safety physicians, it added.
     
    "Based on our strong commitment to safety, all clinical studies conducted by the Janssen Pharmaceutical Companies of Johnson & Johnson have pre-specified guidelines. These ensure our studies may be paused if an unexpected serious adverse event (SAE) that might be related to a vaccine or study drug is reported, so there can be a careful review of all of the medical information before deciding whether to restart the study," the company statement further said.
     
    "We must respect this participant's privacy. We're also learning more about this participant's illness, and it's important to have all the facts before we share additional information.
     
    "Serious adverse events are not uncommon in clinical trials, and the number of serious adverse events can reasonably be expected to increase in trials involving large numbers of participants. Further, as many trials are placebo-controlled, it is not always immediately apparent whether a participant received a study treatment or a placebo," it added
     
    The vaccine is being developed by the company's Janssen arm, CNN said in a news report.
     
    The company however, did not mention what the illness was.
     
    Trials are stopped when they pop up while doctors check to see if the illness can be linked to the vaccine or is a coincidence.
     
    Johnson's Phase 3 trial started in September and it id one of six coronavirus vaccines being tested in the US, and one of four in the most advanced, Phase 3 stage.
     
    This is the second Phase 3 coronavirus vaccine trial to be paused in the US.
     
    AstraZeneca's vaccine trial was paused last month because of a neurological complication in a volunteer in the UK.
     
    While the trial resumed in the UK and in other countries, it remains halted in the US while it is being probed by the Food and Drug Administration investigates.
     
    Disclaimer: Information, facts or opinions expressed in this news article are presented as sourced from IANS and do not reflect views of Moneylife and hence Moneylife is not responsible or liable for the same. As a source and news provider, IANS is responsible for accuracy, completeness, suitability and validity of any information in this article.
  • Like this story? Get our top stories by email.

    User 

    We are listening!

    Solve the equation and enter in the Captcha field.
      Loading...
    Close

    To continue


    Please
    Sign Up or Sign In
    with

    Email
    Close

    To continue


    Please
    Sign Up or Sign In
    with

    Email

    BUY NOW

    online financial advisory
    Pathbreakers
    Pathbreakers 1 & Pathbreakers 2 contain deep insights, unknown facts and captivating events in the life of 51 top achievers, in their own words.
    online financia advisory
    The Scam
    24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
    Moneylife Online Magazine
    Fiercely independent and pro-consumer information on personal finance
    financial magazines online
    Stockletters in 4 Flavours
    Outstanding research that beats mutual funds year after year
    financial magazines in india
    MAS: Complete Online Financial Advisory
    (Includes Moneylife Online Magazine)
    FREE: Your Complete Family Record Book
    Keep all the Personal and Financial Details of You & Your Family. In One Place So That`s Its Easy for Anyone to Find Anytime
    We promise not to share your email id with anyone